Helus Pharma Inc. (HELP) stock
HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
$8.86−0.53 (-5.64%)
Close on Nov 12, 2026Market cap $457.46MP/E –Yield –
Helus Pharma cash
Cash and short-term investments held at the end of each period.
Helus Pharma's cash was C$135.02M at Mar 31, 2025. For fiscal 2025 it was C$135.02M, down 35.4% from the year before. The highest annual figure on record is C$208.99M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | C$135.02M | -35.4% |
| FY2024 | Mar 31, 2024 | C$208.99M | +1156.5% |
| FY2023 | Mar 31, 2023 | C$16.63M | -69.0% |
| FY2022 | Mar 31, 2022 | C$53.64M | -16.2% |
| FY2021 | Mar 31, 2021 | C$64.03M | +4044.1% |
| FY2020 | Mar 31, 2020 | C$1.55M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | C$135.02M | +110.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | C$208.99M | +13427.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | C$16.63M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | C$53.64M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | C$64.03M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | C$1.55M | – |
See a number that looks wrong?